Can an app kick the vaping habit? new trial tests digital therapy for teens
NCT ID NCT06662305
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests whether a smartphone app called Kick-Nic! can help high school students (ages 13-19) quit vaping. About 306 participants who want to quit will either use the app or visit a standard quit-vaping website for 8 weeks. Researchers will check if they've stopped vaping using self-reports and saliva tests, and follow up for 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Kick-Nic! mobile app (behavioral intervention)
- What this could lead to
- If successful, this app could provide an effective, accessible tool to help teenagers quit vaping.
- What could go wrong
- This is a Phase 2 trial with 306 participants, so results are preliminary. The app may not outperform the control website, and long-term abstinence is hard to maintain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NICOTINE VAPING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale University School of Medicine (Connecticut Mental Health Center)
RECRUITINGNew Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study reveals how price shifts smokers' preferences for alternative nicotine products
- New study tests social media and chatbot to help teens kick vaping habit
- Tobacco study reveals how penalties and product rules affect illegal purchases
- Synthetic vs. natural nicotine: which hits harder?
- E-Cigarette study reveals how nicotine hits the bloodstream